Episode 53: Leveraging the FDA's Warning Letters with Michael Tyo

Automating Quality

Contenuto fornito da SOLABS, Mandy Gervasio, and Philippe Gaudreau. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da SOLABS, Mandy Gervasio, and Philippe Gaudreau o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

6M ago 18:35

MP3•Pagina principale dell'episodio

Welcome to Automating Quality, the Life Sciences centric show that bridges the gap between automation and quality management systems. In this episode, guest Michael Tyo discusses how warning letters can be leveraged as a source of information on the FDA’s current areas of focus and how monitoring them can help avoid the FDA’s attention.

Key Takeaways

01:04: Michael introduces himself and his background

02:21: How can companies use warning letters as a source of information on the FDA’s current area of focus

04:31: Michael shares a statistical analysis he conducted on warning letters in 2023

08:52: How warning letters give you an idea of what happened at the company

12:31: Understanding warning letters helps companies avoid the FDA’s attention

56 episodi

#Careers #Business #SOLABS #Philippe Gaudreau #Mandy Gervasio #Science #Biology